Our September issue is live

In this large edition we include over 30 profiles of active partnering companies and a selection of editorials all focused on either antibody technologies, immuno-oncology or cell and gene therapies.

Advertisement

Advances in antibody technologies

Advances in antibody technologies

Development in antibody technologies continues to diversify, providing a rich pipeline of new and innovative therapeutics. In this collection, we present antibody-focused companies, along with their technologies and therapies.
Collection